Quarterly Result12 Aug 2026, 07:11 pm
Kabra Drugs Declares Unaudited Standalone Financial Results for Q1 FY27
AI Summary
Aanjaay Industries Limited (formerly Kabra Drugs Limited) has announced its unaudited standalone financial results for the quarter ended June 30, 2026. The company's Board of Directors approved these results on August 12th, 2026, following a limited review by the statutory auditors. The results are prepared in accordance with Ind AS 34 "Interim Financial Reporting". The company operates in a single business segment and does not have any subsidiaries or associate entities. Earnings Per Share (EPS) is not annualized for the quarterly results.
Key Highlights
- Unaudited standalone financial results declared for Q1 FY27.
- Results approved by the Board of Directors on August 12th, 2026.
- Statutory auditors conducted a limited review of the financial results.
- Company operates in a single business segment.
- EPS is not annualized for the quarterly results.
Price Impact
More from KABRADG